Article Information
History
- June 23, 2022.
Article Versions
- You are currently viewing Version 1 of this article (June 23, 2022 - 13:51).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Christian Federau1,2,*,
- Nicolin Hainc2,3,
- Myriam Edjlali-Goujon4,
- Guangming Zhu5,
- Milica Mastilovic4,
- Nathalie Nierobisch2,3,
- Jan-Philipp Uhlemann2,3,
- Silvio Paganucci1,
- Cristina Granziera6,
- Lucas B. Kipp7 and
- Max Wintermark5,8
- 1AI Medical AG, Zollikon, Switzerland
- 2University of Zürich, Zürich, Switzerland
- 3Department of Neuroradiology, Clinical Neuroscience Center, University Hospital Zurich, University of Zurich, Zurich, Switzerland
- 4Centre Hospitalier St-Anne, Paris, France
- 5Stanford University, Stanford, USA
- 6University Hospital Basel and University of Basel, Basel, Switzerland
- 7Department of Neurology & Neurological Sciences, Stanford University School of Medicine, Stanford, CA, USA
- 8MD Anderson Cancer Center, Houston, USA
- ↵*Corresponding Author: Christian Federau, AI Medical AG, Goldhaldenstr 22a, 8702 Zollikon, Switzerland. christian{at}ai-medical.ch
Posted June 23, 2022.
Improved Detection, Description and Efficiency of Multiple Sclerosis Neuroradiological Lesions’ Assessment using a Semi-Automatic Dedicated Deep-Learning Based Software Jazz
